HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The antibody response to well-defined malaria antigens after acute malaria in individuals living under continuous malaria transmission.

Abstract
The IgG and IgM antibody responses to the C-terminal 783 amino acids of the P. falciparum glutamate-rich protein, GLURP489-1271, expressed as an E. coli fusion protein, the IgG response to a 18-mer synthetic peptide EDKNEKGQHEIVEVEEIL (GLURP899-916) representing the C-terminal repeats of GLURP, and a synthetic peptide (EENV)6 representing the C-terminal repeats from Pf155/RESA, were investigated longitudinally in 13 children and 7 adults living under conditions of continuous, intense malaria transmission. Some subjects did not recognize the antigens after malaria infection, and in subjects recognizing the antigens, the responses were often short-lived. In adults, the antibody responses to the GLURP489-1271 fusion protein and the (EENV)6 peptide peaked after 2 weeks, and not all individuals responded to all antigens. The antibody response, even against large fragments of conserved antigens, is not uniformly elicited by natural malaria infection in previously primed donors.
AuthorsE Petersen, B Høgh, M Dziegiel, M Borre, A Björkman, N T Marbiah, E Dolopaye, A P Hanson, S Jepsen
JournalActa tropica (Acta Trop) Vol. 51 Issue 2 Pg. 135-42 (Jun 1992) ISSN: 0001-706X [Print] Netherlands
PMID1354931 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Protozoan
  • Immunoglobulin G
  • Immunoglobulin M
  • Protozoan Proteins
  • glutamate-rich protein, Plasmodium
Topics
  • Adolescent
  • Adult
  • Amino Acid Sequence
  • Animals
  • Antibodies, Protozoan (immunology)
  • Female
  • Humans
  • Immunoglobulin G (immunology)
  • Immunoglobulin M (immunology)
  • Malaria, Falciparum (immunology)
  • Male
  • Molecular Sequence Data
  • Plasmodium falciparum (immunology)
  • Protozoan Proteins (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: